ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ovulation Induction Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-11D12984
Home | Market Reports | Health| Reproductive Health
Global Ovulation Induction Market Research Report 2022
BUY CHAPTERS

Global Ovulation Induction Market Research Report 2025

Code: QYRE-Auto-11D12984
Report
March 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck& Co. Inc
AbbVie
Takeda
Ferring
Astrazeneca plc
Ipsen S A
Bristol–Myers Squibb
Sun Pharmaceutical
Gedeon Richter
IBSA
LIVZON
Sanofi
EMD Serono Inc
TerSera Therapeutics
Techwell
Endo
Par Pharmaceutical Inc.
Cosette Pharmaceuticals, Inc
Pharmascience
Teva Pharmaceuticals Usa Inc
Pacific Pharmaceuticals
IBM Micromedex
Emcure Pharmaceuticals Ltd.
Unichem Laboratories

Ovulation Induction Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Ovulation Induction Market

Ovulation Induction Market

The global market for Ovulation Induction was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ovulation Induction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ovulation Induction.
The Ovulation Induction market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ovulation Induction market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ovulation Induction companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Ovulation Induction Market Report

Report Metric Details
Report Name Ovulation Induction Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Medical Institution
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck & Co. Inc, AbbVie, Takeda, Ferring, AstraZeneca, Ipsen, Bristol Myers Squibb, Sun Pharmaceutical, Fresenius Kabi, Gedeon Richter, IBSA, LIVZON, Sanofi, EMD Serono Inc, TerSera Therapeutics, Techwell, Endo, Par pharmaceutical inc, Cosette Pharmaceuticals, Inc, Pharmascience Inc, Teva Pharmaceuticals USA, Inc, Pacific Pharmaceuticals, IBM Micromedex, Emcure Pharmaceuticals Ltd., Unichem Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Ovulation Induction company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Ovulation Induction Market report?

Ans: The main players in the Ovulation Induction Market are Merck & Co. Inc, AbbVie, Takeda, Ferring, AstraZeneca, Ipsen, Bristol Myers Squibb, Sun Pharmaceutical, Fresenius Kabi, Gedeon Richter, IBSA, LIVZON, Sanofi, EMD Serono Inc, TerSera Therapeutics, Techwell, Endo, Par pharmaceutical inc, Cosette Pharmaceuticals, Inc, Pharmascience Inc, Teva Pharmaceuticals USA, Inc, Pacific Pharmaceuticals, IBM Micromedex, Emcure Pharmaceuticals Ltd., Unichem Laboratories

What are the Application segmentation covered in the Ovulation Induction Market report?

Ans: The Applications covered in the Ovulation Induction Market report are Hospital, Clinic, Medical Institution

What are the Type segmentation covered in the Ovulation Induction Market report?

Ans: The Types covered in the Ovulation Induction Market report are Follicle Stimulating Hormone, Human Chorionic Gonadotropin, Human Menopausal Gonadotropin, Clomiphene Citrate, Others

Recommended Reports

Fertility & Reproduction

Pharmaceutical Services

Women's Health

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ovulation Induction Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Follicle Stimulating Hormone
1.2.3 Human Chorionic Gonadotropin
1.2.4 Human Menopausal Gonadotropin
1.2.5 Clomiphene Citrate
1.2.6 Others
1.3 Market by Application
1.3.1 Global Ovulation Induction Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Institution
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ovulation Induction Market Perspective (2020-2031)
2.2 Global Ovulation Induction Growth Trends by Region
2.2.1 Global Ovulation Induction Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Ovulation Induction Historic Market Size by Region (2020-2025)
2.2.3 Ovulation Induction Forecasted Market Size by Region (2026-2031)
2.3 Ovulation Induction Market Dynamics
2.3.1 Ovulation Induction Industry Trends
2.3.2 Ovulation Induction Market Drivers
2.3.3 Ovulation Induction Market Challenges
2.3.4 Ovulation Induction Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ovulation Induction Players by Revenue
3.1.1 Global Top Ovulation Induction Players by Revenue (2020-2025)
3.1.2 Global Ovulation Induction Revenue Market Share by Players (2020-2025)
3.2 Global Ovulation Induction Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Ovulation Induction Revenue
3.4 Global Ovulation Induction Market Concentration Ratio
3.4.1 Global Ovulation Induction Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ovulation Induction Revenue in 2024
3.5 Global Key Players of Ovulation Induction Head office and Area Served
3.6 Global Key Players of Ovulation Induction, Product and Application
3.7 Global Key Players of Ovulation Induction, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ovulation Induction Breakdown Data by Type
4.1 Global Ovulation Induction Historic Market Size by Type (2020-2025)
4.2 Global Ovulation Induction Forecasted Market Size by Type (2026-2031)
5 Ovulation Induction Breakdown Data by Application
5.1 Global Ovulation Induction Historic Market Size by Application (2020-2025)
5.2 Global Ovulation Induction Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Ovulation Induction Market Size (2020-2031)
6.2 North America Ovulation Induction Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Ovulation Induction Market Size by Country (2020-2025)
6.4 North America Ovulation Induction Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ovulation Induction Market Size (2020-2031)
7.2 Europe Ovulation Induction Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Ovulation Induction Market Size by Country (2020-2025)
7.4 Europe Ovulation Induction Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ovulation Induction Market Size (2020-2031)
8.2 Asia-Pacific Ovulation Induction Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Ovulation Induction Market Size by Region (2020-2025)
8.4 Asia-Pacific Ovulation Induction Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ovulation Induction Market Size (2020-2031)
9.2 Latin America Ovulation Induction Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Ovulation Induction Market Size by Country (2020-2025)
9.4 Latin America Ovulation Induction Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ovulation Induction Market Size (2020-2031)
10.2 Middle East & Africa Ovulation Induction Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Ovulation Induction Market Size by Country (2020-2025)
10.4 Middle East & Africa Ovulation Induction Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co. Inc
11.1.1 Merck & Co. Inc Company Details
11.1.2 Merck & Co. Inc Business Overview
11.1.3 Merck & Co. Inc Ovulation Induction Introduction
11.1.4 Merck & Co. Inc Revenue in Ovulation Induction Business (2020-2025)
11.1.5 Merck & Co. Inc Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Ovulation Induction Introduction
11.2.4 AbbVie Revenue in Ovulation Induction Business (2020-2025)
11.2.5 AbbVie Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Ovulation Induction Introduction
11.3.4 Takeda Revenue in Ovulation Induction Business (2020-2025)
11.3.5 Takeda Recent Development
11.4 Ferring
11.4.1 Ferring Company Details
11.4.2 Ferring Business Overview
11.4.3 Ferring Ovulation Induction Introduction
11.4.4 Ferring Revenue in Ovulation Induction Business (2020-2025)
11.4.5 Ferring Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Ovulation Induction Introduction
11.5.4 AstraZeneca Revenue in Ovulation Induction Business (2020-2025)
11.5.5 AstraZeneca Recent Development
11.6 Ipsen
11.6.1 Ipsen Company Details
11.6.2 Ipsen Business Overview
11.6.3 Ipsen Ovulation Induction Introduction
11.6.4 Ipsen Revenue in Ovulation Induction Business (2020-2025)
11.6.5 Ipsen Recent Development
11.7 Bristol Myers Squibb
11.7.1 Bristol Myers Squibb Company Details
11.7.2 Bristol Myers Squibb Business Overview
11.7.3 Bristol Myers Squibb Ovulation Induction Introduction
11.7.4 Bristol Myers Squibb Revenue in Ovulation Induction Business (2020-2025)
11.7.5 Bristol Myers Squibb Recent Development
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Details
11.8.2 Sun Pharmaceutical Business Overview
11.8.3 Sun Pharmaceutical Ovulation Induction Introduction
11.8.4 Sun Pharmaceutical Revenue in Ovulation Induction Business (2020-2025)
11.8.5 Sun Pharmaceutical Recent Development
11.9 Fresenius Kabi
11.9.1 Fresenius Kabi Company Details
11.9.2 Fresenius Kabi Business Overview
11.9.3 Fresenius Kabi Ovulation Induction Introduction
11.9.4 Fresenius Kabi Revenue in Ovulation Induction Business (2020-2025)
11.9.5 Fresenius Kabi Recent Development
11.10 Gedeon Richter
11.10.1 Gedeon Richter Company Details
11.10.2 Gedeon Richter Business Overview
11.10.3 Gedeon Richter Ovulation Induction Introduction
11.10.4 Gedeon Richter Revenue in Ovulation Induction Business (2020-2025)
11.10.5 Gedeon Richter Recent Development
11.11 IBSA
11.11.1 IBSA Company Details
11.11.2 IBSA Business Overview
11.11.3 IBSA Ovulation Induction Introduction
11.11.4 IBSA Revenue in Ovulation Induction Business (2020-2025)
11.11.5 IBSA Recent Development
11.12 LIVZON
11.12.1 LIVZON Company Details
11.12.2 LIVZON Business Overview
11.12.3 LIVZON Ovulation Induction Introduction
11.12.4 LIVZON Revenue in Ovulation Induction Business (2020-2025)
11.12.5 LIVZON Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Ovulation Induction Introduction
11.13.4 Sanofi Revenue in Ovulation Induction Business (2020-2025)
11.13.5 Sanofi Recent Development
11.14 EMD Serono Inc
11.14.1 EMD Serono Inc Company Details
11.14.2 EMD Serono Inc Business Overview
11.14.3 EMD Serono Inc Ovulation Induction Introduction
11.14.4 EMD Serono Inc Revenue in Ovulation Induction Business (2020-2025)
11.14.5 EMD Serono Inc Recent Development
11.15 TerSera Therapeutics
11.15.1 TerSera Therapeutics Company Details
11.15.2 TerSera Therapeutics Business Overview
11.15.3 TerSera Therapeutics Ovulation Induction Introduction
11.15.4 TerSera Therapeutics Revenue in Ovulation Induction Business (2020-2025)
11.15.5 TerSera Therapeutics Recent Development
11.16 Techwell
11.16.1 Techwell Company Details
11.16.2 Techwell Business Overview
11.16.3 Techwell Ovulation Induction Introduction
11.16.4 Techwell Revenue in Ovulation Induction Business (2020-2025)
11.16.5 Techwell Recent Development
11.17 Endo
11.17.1 Endo Company Details
11.17.2 Endo Business Overview
11.17.3 Endo Ovulation Induction Introduction
11.17.4 Endo Revenue in Ovulation Induction Business (2020-2025)
11.17.5 Endo Recent Development
11.18 Par pharmaceutical inc
11.18.1 Par pharmaceutical inc Company Details
11.18.2 Par pharmaceutical inc Business Overview
11.18.3 Par pharmaceutical inc Ovulation Induction Introduction
11.18.4 Par pharmaceutical inc Revenue in Ovulation Induction Business (2020-2025)
11.18.5 Par pharmaceutical inc Recent Development
11.19 Cosette Pharmaceuticals, Inc
11.19.1 Cosette Pharmaceuticals, Inc Company Details
11.19.2 Cosette Pharmaceuticals, Inc Business Overview
11.19.3 Cosette Pharmaceuticals, Inc Ovulation Induction Introduction
11.19.4 Cosette Pharmaceuticals, Inc Revenue in Ovulation Induction Business (2020-2025)
11.19.5 Cosette Pharmaceuticals, Inc Recent Development
11.20 Pharmascience Inc
11.20.1 Pharmascience Inc Company Details
11.20.2 Pharmascience Inc Business Overview
11.20.3 Pharmascience Inc Ovulation Induction Introduction
11.20.4 Pharmascience Inc Revenue in Ovulation Induction Business (2020-2025)
11.20.5 Pharmascience Inc Recent Development
11.21 Teva Pharmaceuticals USA, Inc
11.21.1 Teva Pharmaceuticals USA, Inc Company Details
11.21.2 Teva Pharmaceuticals USA, Inc Business Overview
11.21.3 Teva Pharmaceuticals USA, Inc Ovulation Induction Introduction
11.21.4 Teva Pharmaceuticals USA, Inc Revenue in Ovulation Induction Business (2020-2025)
11.21.5 Teva Pharmaceuticals USA, Inc Recent Development
11.22 Pacific Pharmaceuticals
11.22.1 Pacific Pharmaceuticals Company Details
11.22.2 Pacific Pharmaceuticals Business Overview
11.22.3 Pacific Pharmaceuticals Ovulation Induction Introduction
11.22.4 Pacific Pharmaceuticals Revenue in Ovulation Induction Business (2020-2025)
11.22.5 Pacific Pharmaceuticals Recent Development
11.23 IBM Micromedex
11.23.1 IBM Micromedex Company Details
11.23.2 IBM Micromedex Business Overview
11.23.3 IBM Micromedex Ovulation Induction Introduction
11.23.4 IBM Micromedex Revenue in Ovulation Induction Business (2020-2025)
11.23.5 IBM Micromedex Recent Development
11.24 Emcure Pharmaceuticals Ltd.
11.24.1 Emcure Pharmaceuticals Ltd. Company Details
11.24.2 Emcure Pharmaceuticals Ltd. Business Overview
11.24.3 Emcure Pharmaceuticals Ltd. Ovulation Induction Introduction
11.24.4 Emcure Pharmaceuticals Ltd. Revenue in Ovulation Induction Business (2020-2025)
11.24.5 Emcure Pharmaceuticals Ltd. Recent Development
11.25 Unichem Laboratories
11.25.1 Unichem Laboratories Company Details
11.25.2 Unichem Laboratories Business Overview
11.25.3 Unichem Laboratories Ovulation Induction Introduction
11.25.4 Unichem Laboratories Revenue in Ovulation Induction Business (2020-2025)
11.25.5 Unichem Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Merck& Co. Inc
AbbVie
Takeda
Ferring
Astrazeneca plc
Ipsen S A
Bristol–Myers Squibb
Sun Pharmaceutical
Gedeon Richter
IBSA
LIVZON
Sanofi
EMD Serono Inc
TerSera Therapeutics
Techwell
Endo
Par Pharmaceutical Inc.
Cosette Pharmaceuticals, Inc
Pharmascience
Teva Pharmaceuticals Usa Inc
Pacific Pharmaceuticals
IBM Micromedex
Emcure Pharmaceuticals Ltd.
Unichem Laboratories
List of Tables
 Table 1. Global Ovulation Induction Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Follicle Stimulating Hormone
 Table 3. Key Players of Human Chorionic Gonadotropin
 Table 4. Key Players of Human Menopausal Gonadotropin
 Table 5. Key Players of Clomiphene Citrate
 Table 6. Key Players of Others
 Table 7. Global Ovulation Induction Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Ovulation Induction Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Ovulation Induction Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Ovulation Induction Market Share by Region (2020-2025)
 Table 11. Global Ovulation Induction Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Ovulation Induction Market Share by Region (2026-2031)
 Table 13. Ovulation Induction Market Trends
 Table 14. Ovulation Induction Market Drivers
 Table 15. Ovulation Induction Market Challenges
 Table 16. Ovulation Induction Market Restraints
 Table 17. Global Ovulation Induction Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Ovulation Induction Market Share by Players (2020-2025)
 Table 19. Global Top Ovulation Induction Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovulation Induction as of 2024)
 Table 20. Ranking of Global Top Ovulation Induction Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Ovulation Induction Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Ovulation Induction, Headquarters and Area Served
 Table 23. Global Key Players of Ovulation Induction, Product and Application
 Table 24. Global Key Players of Ovulation Induction, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Ovulation Induction Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Ovulation Induction Revenue Market Share by Type (2020-2025)
 Table 28. Global Ovulation Induction Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Ovulation Induction Revenue Market Share by Type (2026-2031)
 Table 30. Global Ovulation Induction Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Ovulation Induction Revenue Market Share by Application (2020-2025)
 Table 32. Global Ovulation Induction Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Ovulation Induction Revenue Market Share by Application (2026-2031)
 Table 34. North America Ovulation Induction Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Ovulation Induction Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Ovulation Induction Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Ovulation Induction Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Ovulation Induction Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Ovulation Induction Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Ovulation Induction Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Ovulation Induction Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Ovulation Induction Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Ovulation Induction Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Ovulation Induction Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Ovulation Induction Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Ovulation Induction Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Ovulation Induction Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Ovulation Induction Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Merck & Co. Inc Company Details
 Table 50. Merck & Co. Inc Business Overview
 Table 51. Merck & Co. Inc Ovulation Induction Product
 Table 52. Merck & Co. Inc Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 53. Merck & Co. Inc Recent Development
 Table 54. AbbVie Company Details
 Table 55. AbbVie Business Overview
 Table 56. AbbVie Ovulation Induction Product
 Table 57. AbbVie Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 58. AbbVie Recent Development
 Table 59. Takeda Company Details
 Table 60. Takeda Business Overview
 Table 61. Takeda Ovulation Induction Product
 Table 62. Takeda Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 63. Takeda Recent Development
 Table 64. Ferring Company Details
 Table 65. Ferring Business Overview
 Table 66. Ferring Ovulation Induction Product
 Table 67. Ferring Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 68. Ferring Recent Development
 Table 69. AstraZeneca Company Details
 Table 70. AstraZeneca Business Overview
 Table 71. AstraZeneca Ovulation Induction Product
 Table 72. AstraZeneca Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 73. AstraZeneca Recent Development
 Table 74. Ipsen Company Details
 Table 75. Ipsen Business Overview
 Table 76. Ipsen Ovulation Induction Product
 Table 77. Ipsen Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 78. Ipsen Recent Development
 Table 79. Bristol Myers Squibb Company Details
 Table 80. Bristol Myers Squibb Business Overview
 Table 81. Bristol Myers Squibb Ovulation Induction Product
 Table 82. Bristol Myers Squibb Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 83. Bristol Myers Squibb Recent Development
 Table 84. Sun Pharmaceutical Company Details
 Table 85. Sun Pharmaceutical Business Overview
 Table 86. Sun Pharmaceutical Ovulation Induction Product
 Table 87. Sun Pharmaceutical Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 88. Sun Pharmaceutical Recent Development
 Table 89. Fresenius Kabi Company Details
 Table 90. Fresenius Kabi Business Overview
 Table 91. Fresenius Kabi Ovulation Induction Product
 Table 92. Fresenius Kabi Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 93. Fresenius Kabi Recent Development
 Table 94. Gedeon Richter Company Details
 Table 95. Gedeon Richter Business Overview
 Table 96. Gedeon Richter Ovulation Induction Product
 Table 97. Gedeon Richter Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 98. Gedeon Richter Recent Development
 Table 99. IBSA Company Details
 Table 100. IBSA Business Overview
 Table 101. IBSA Ovulation Induction Product
 Table 102. IBSA Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 103. IBSA Recent Development
 Table 104. LIVZON Company Details
 Table 105. LIVZON Business Overview
 Table 106. LIVZON Ovulation Induction Product
 Table 107. LIVZON Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 108. LIVZON Recent Development
 Table 109. Sanofi Company Details
 Table 110. Sanofi Business Overview
 Table 111. Sanofi Ovulation Induction Product
 Table 112. Sanofi Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 113. Sanofi Recent Development
 Table 114. EMD Serono Inc Company Details
 Table 115. EMD Serono Inc Business Overview
 Table 116. EMD Serono Inc Ovulation Induction Product
 Table 117. EMD Serono Inc Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 118. EMD Serono Inc Recent Development
 Table 119. TerSera Therapeutics Company Details
 Table 120. TerSera Therapeutics Business Overview
 Table 121. TerSera Therapeutics Ovulation Induction Product
 Table 122. TerSera Therapeutics Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 123. TerSera Therapeutics Recent Development
 Table 124. Techwell Company Details
 Table 125. Techwell Business Overview
 Table 126. Techwell Ovulation Induction Product
 Table 127. Techwell Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 128. Techwell Recent Development
 Table 129. Endo Company Details
 Table 130. Endo Business Overview
 Table 131. Endo Ovulation Induction Product
 Table 132. Endo Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 133. Endo Recent Development
 Table 134. Par pharmaceutical inc Company Details
 Table 135. Par pharmaceutical inc Business Overview
 Table 136. Par pharmaceutical inc Ovulation Induction Product
 Table 137. Par pharmaceutical inc Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 138. Par pharmaceutical inc Recent Development
 Table 139. Cosette Pharmaceuticals, Inc Company Details
 Table 140. Cosette Pharmaceuticals, Inc Business Overview
 Table 141. Cosette Pharmaceuticals, Inc Ovulation Induction Product
 Table 142. Cosette Pharmaceuticals, Inc Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 143. Cosette Pharmaceuticals, Inc Recent Development
 Table 144. Pharmascience Inc Company Details
 Table 145. Pharmascience Inc Business Overview
 Table 146. Pharmascience Inc Ovulation Induction Product
 Table 147. Pharmascience Inc Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 148. Pharmascience Inc Recent Development
 Table 149. Teva Pharmaceuticals USA, Inc Company Details
 Table 150. Teva Pharmaceuticals USA, Inc Business Overview
 Table 151. Teva Pharmaceuticals USA, Inc Ovulation Induction Product
 Table 152. Teva Pharmaceuticals USA, Inc Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 153. Teva Pharmaceuticals USA, Inc Recent Development
 Table 154. Pacific Pharmaceuticals Company Details
 Table 155. Pacific Pharmaceuticals Business Overview
 Table 156. Pacific Pharmaceuticals Ovulation Induction Product
 Table 157. Pacific Pharmaceuticals Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 158. Pacific Pharmaceuticals Recent Development
 Table 159. IBM Micromedex Company Details
 Table 160. IBM Micromedex Business Overview
 Table 161. IBM Micromedex Ovulation Induction Product
 Table 162. IBM Micromedex Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 163. IBM Micromedex Recent Development
 Table 164. Emcure Pharmaceuticals Ltd. Company Details
 Table 165. Emcure Pharmaceuticals Ltd. Business Overview
 Table 166. Emcure Pharmaceuticals Ltd. Ovulation Induction Product
 Table 167. Emcure Pharmaceuticals Ltd. Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 168. Emcure Pharmaceuticals Ltd. Recent Development
 Table 169. Unichem Laboratories Company Details
 Table 170. Unichem Laboratories Business Overview
 Table 171. Unichem Laboratories Ovulation Induction Product
 Table 172. Unichem Laboratories Revenue in Ovulation Induction Business (2020-2025) & (US$ Million)
 Table 173. Unichem Laboratories Recent Development
 Table 174. Research Programs/Design for This Report
 Table 175. Key Data Information from Secondary Sources
 Table 176. Key Data Information from Primary Sources
 Table 177. Authors List of This Report


List of Figures
 Figure 1. Ovulation Induction Picture
 Figure 2. Global Ovulation Induction Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ovulation Induction Market Share by Type: 2024 VS 2031
 Figure 4. Follicle Stimulating Hormone Features
 Figure 5. Human Chorionic Gonadotropin Features
 Figure 6. Human Menopausal Gonadotropin Features
 Figure 7. Clomiphene Citrate Features
 Figure 8. Others Features
 Figure 9. Global Ovulation Induction Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Ovulation Induction Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Case Studies
 Figure 12. Clinic Case Studies
 Figure 13. Medical Institution Case Studies
 Figure 14. Ovulation Induction Report Years Considered
 Figure 15. Global Ovulation Induction Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Ovulation Induction Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Ovulation Induction Market Share by Region: 2024 VS 2031
 Figure 18. Global Ovulation Induction Market Share by Players in 2024
 Figure 19. Global Top Ovulation Induction Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovulation Induction as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Ovulation Induction Revenue in 2024
 Figure 21. North America Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Ovulation Induction Market Share by Country (2020-2031)
 Figure 23. United States Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Ovulation Induction Market Share by Country (2020-2031)
 Figure 27. Germany Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Ovulation Induction Market Share by Region (2020-2031)
 Figure 35. China Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Ovulation Induction Market Share by Country (2020-2031)
 Figure 43. Mexico Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Ovulation Induction Market Share by Country (2020-2031)
 Figure 47. Turkey Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Ovulation Induction Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Merck & Co. Inc Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 51. AbbVie Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 52. Takeda Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 53. Ferring Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 54. AstraZeneca Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 55. Ipsen Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 56. Bristol Myers Squibb Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 57. Sun Pharmaceutical Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 58. Fresenius Kabi Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 59. Gedeon Richter Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 60. IBSA Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 61. LIVZON Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 62. Sanofi Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 63. EMD Serono Inc Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 64. TerSera Therapeutics Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 65. Techwell Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 66. Endo Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 67. Par pharmaceutical inc Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 68. Cosette Pharmaceuticals, Inc Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 69. Pharmascience Inc Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 70. Teva Pharmaceuticals USA, Inc Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 71. Pacific Pharmaceuticals Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 72. IBM Micromedex Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 73. Emcure Pharmaceuticals Ltd. Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 74. Unichem Laboratories Revenue Growth Rate in Ovulation Induction Business (2020-2025)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Reproductive and Fertility Diagnosis Market Research Report 2025
Fertility Treatments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assisted Reproduction Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assisted Reproductive Technology Drugs Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Obstetrics and Gynecology Drugs Market Research Report 2025
Global Hormonal Infertility Treatment Market Research Report 2022
Global Female Contraception Drug Market Research Report 2024
Global Gravid Treatment Market Research Report 2024
Amenorrhea Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pregnancy Medication Market Research Report 2025
Global Polycystic Ovary Syndrome PCOS Drugs Market Research Report 2024
Global Gynecological Cancers Drug Market Research Report 2025
Global Oral Contraceptive Market Research Report 2024
Estrogen Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Menopause Hormonal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Menopause Hormonal Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fetal Monitoring and Diagnostics Test Market Research Report 2024
Global Overactive Bladder OAB Bionic Drug Market Research Report 2025
Global Pill Organizer with Timer Reminder Market Research Report 2025
Global Photoinitiator Drug Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions